36 results about "Dietary Formulations" patented technology

The present invention provides dietary formulations comprising polyunsaturated fatty acids and vitamin E. The present invention further provides methods of treating various conditions, generally involving administering to an individual in need thereof an effective amount of a subject dietary formulation.

Disclosed herein are dietary formulations and methods to mimic the physiological, biochemical and gene expression effects of calorie restriction without altering dietary intake. The formulations include combinations of nutrients that have various intended functions in the body, falling into three or more of the following activities; (1) antioxidant activity; (2) inhibition of glycation damage; (3) reduction of body weight and fat; and (4) promotion of high insulin sensitivity and low blood insulin / glucose; and (5) anti-inflammatory activity.

The invention provides methods, compositions, and dietary formulations useful for managing blood glucose, preventing or treating insulin resistance, and improving insulin sensitivity. The methods comprise administering to an animal a therapeutically effective amount of a combination of at least two of one or more antioxidants; one or more anti-glycation agents; one or more body fat reducing agents; one or more insulin sensitivity enhancing agents; and one or more anti-inflammatory agents.

The invention is directed to water-dispersible, substantially homogeneous artificial diets and diet formulations which provide honey bees with a fully nutritious, complex mixture of proteins, carbohydrates, fats, minerals, and vitamins in an easily digestible form. The diets of the invention support growth and development of honey bees, sustain brood rearing, and maintain hive vigor, and thus make possible the continuous rearing of bees using an artificial diet. The invention diets are useful for many purposes, and are particularly advantageous for providing nutrition sources for bees that are moved during commercial crop pollination or for other migratory beekeeping uses.

Dietary formulations in the form of an oil emulsion providing total enteral or parenteral nutrition, or in the form of food oil suitable for oral administration is provided. The formulations include about 2-60% by calories of a C20 or longer omega-3 fatty acid and about 0.05% to 1% by calories of arachidonic acid, where the formulation provides less than 1% of total calories from linoleic acid and alpha-linolenic acid, and where the fatty acids provide 5-60% of the total calories of said dietary formulation. Methods for treatment of diseases and disorders using the dietary formulations are also provided.

The present invention relates to the field of nutritional support for individuals and reducing the effects of muscle conditions caused by high levels of physical activity. In particular, the invention provides dietary formulations, compositions comprising these formulations and uses of these compositions to support the body's muscle regeneration process.

Dietary formulations and methods for treating, preventing or delay onset of osteoarthritis in canines and other animals are disclosed. The formulations are enriched in n-3 fatty acids and limited in n-6 fatty acids.

The invention discloses a ketogenic diet formula milk and a preparation method thereof and aims to solve the technical problem that convenience is provided for a patient to have food therapy through ketogenic diet. The ketogenic diet formula milk contains the following components per 100 g: 1.5-12.5 g of fat, 0-5 g of protein, 0-0.5 g of carbohydrate, 0-0.6 g of flavoring, 0-1.2 g of nourishing essence and the balance of liquid milk. The preparation method comprises the step of uniformly mixing fat, protein, carbohydrate, flavoring, nourishing essence and the liquid milk according to the prior art. Compared with the prior art, the ketogeic diet formula milk takes human milk and animal milk of which metabolizable sugar is removed as the main raw material, adopts a nutrient formula close to physiological needs, has a good mouthfeel, is easily accepted by the patient, is convenient to take, is suitable for treating epilepsy, diabetes, all kinds of tumors, behavior disorder, autism, brain and spinal cord injuries, and adiposity, and is also suitable for normal people to lose weight and change the structure of the main nutrients of the body, as well as for animal experiments.

The present invention provides a dietary formulation for improving dietary fiber and a processing technique thereof, relating to the industry of functional health-care food. The present invention utilizes grains and cereals, nuts, dried fruits, common yams and innocuous Chinese medicinal herbs and develops a food for improving dietary fiber, especially coarse fiber by a scientific prescription on the basis of traditional Chinese health preservation and care theory according to the fineness and singularity of the modern dietary structure. The dietary formulation and the processing technique of the present invention achieve the aim of disease prevention and treatment by adjusting the dietary structure of three meals in one day.

The present invention provides a dietary formulation for lowering blood pressure and a processing technique thereof, relating to the industry of functional health-care food. The present invention utilizes grains and cereals, nuts, dried fruits, common yams, potherbs and innocuous Chinese medicinal herbs and develops a dietary processing method by a scientific prescription on the basis of traditional Chinese health preservation and care theory, and the method achieves the aim of disease prevention and treatment by adjusting the dietary structure of three meals in one day.

According to the present invention, acquired metabolic derangements or fatty acid disorders in humans that are manifested by a deficiency in at least one enzyme involved in fatty acid metabolism are treated with a five carbon or a fifteen carbon fatty acid source. Rapid nutritional supplementation can also be provided to a mammalian cell by providing either a five carbon or fifteen carbon fatty acid source. Dietary formulations suitable for human consumption comprising either a five carbon fatty acid, a fifteen carbon fatty acid or triglycerides thereof is also disclosed.

The invention discloses a dietary formulation for treating epilepsy, which comprises grease : protein and carbohydrate by the ratio of 3:1-4:1. Compared with the prior art, the invention is characterized in high proportion or grease food, evident curative effect for epilepsy, less toxic and side effects, lower price and good taste.

The invention is directed to water-dispersible, substantially homogeneous artificial diets and diet formulations which provide honey bees with a fully nutritious, complex mixture of proteins, carbohydrates, fats, minerals, and vitamins in an easily digestible form. The diets of the invention support growth and development of honey bees, sustain brood rearing, and maintain hive vigor, and thus make possible the continuous rearing of bees using an artificial diet. The invention diets are useful for many purposes, and are particularly advantageous for providing nutrition sources for bees that are moved during commercial crop pollination or for other migratory beekeeping uses.

A method for mitigating the malodor normally associated with a valerian extract. The method consists of adjusting the apparent pH of an aqueous-alcoholic solution of the valerian extract with a chemical base in order to neutralize the valerian extract. The extract can then be subsequently mixed with a carrier to form a powder. Alternatively, the deodorized valerian extract can be used in pharmaceutical, nutritional or dietary formulations.

The invention discloses a diet supplementary formula and a method of nutrition supplementary food for moderate type II diabetes rehabilitation. Total dosage of nutrition supplementary food ate with normal meal every day comprises 20 g of protein powder, 6 tablets of calcium magnesium, 9 tablets of natural vitamin B and 6 tablets of deep-sea salmon oil. The nutritional substances supplemented with meals are complete and have the health-care function of enhancing immunity, relieving physical fatigue and adjusting blood fat. The invention has obvious treating effect with respect to the rehabilitation of patients aging from 40 to 50 with moderate type II diabetes.

An artificial feeding system for maintenance and growth of hematophagous insects is disclosed to comprise a blood-free diet formulation and a feeding device. The blood-free diet formulation comprises effective amounts of a protein source and a carbohydrate source, wherein the blood-free diet formulation is suitable for egg production and colony maintenance of hematophagous insects. The feeding device comprises a diet reservoir for receiving the blood-free diet formulation and a feeding platform for hematophagous insects to feed the blood-free diet formation from the diet reservoir.

The present invention relates to a method for lowering risk of cardiovascular diseases in human, particularly for lowering low density lipoprotein cholesterol (LDL-C) concentration and oxidative stress level while maintaining sufficient high density lipoprotein cholesterol (HDL-C) concentration in human, and to a dietary formulation and a fat or fat blend suitable for human consumption for resulting in the same. The method is by way of controlling daily dietary fat and antioxidants consumption so that: daily dietary fat accounts for 20-40% of the total daily dietary energy intake; 10-20% wt of the fatty acids in daily dietary fat are saturated fatty acids (SFAs); 20-35% wt of the fatty acids in daily dietary fat are polyunsaturated fatty acids (PUFAs); 45-70% wt of the fatty acids in daily dietary fat are monounsaturated fatty acids (MUFAs); and the ratio of antioxidants to polyunsaturated fatty acids (PUFAs) in daily dietary fat is ranging from about 15-70 ppm antioxidants / % wt PUFAs.

A method of treating patients in need of treatment for a cardiac disorder has been found which comprises administering to the patient a seven carbon fatty acid compound or derivative thereof, wherein the compound or derivative thereof is able to readily enter the mitochondrion without special transport enzymes. A dietary formulation suitable for treatment of heart tissue in cardiac or surgical patients has been found which comprises a seven-carbon fatty acid chain, wherein the seven-carbon fatty acid chain is characterized by the ability to transverse the inner mitochondrial membrane by a transport mechanism which does not require carnitine palmitoyltransferase I, carnitine palmitoyltransferase II, or carnitine / acylcarnitine translocase and the ability to undergo mitochondrial β-oxidation, and wherein the compound is selected from the group consisting of n-heptanoic acid or a derivative thereof, a triglyceride comprising n-heptanoic acid or a derivative thereof, and triheptanoin or a derivative thereof.

The invention provides methods, compositions, and dietary formulations useful for preventing or treating dermatitis, promoting healthy skin, and retarding skin aging. The methods comprise administering to an animal a therapeutically effective amount of a combination of at least two of one or more antioxidants; one or more anti-glycation agents; one or more body fat reducing agents; one or more insulin sensitivity enhancing agents; and one or more anti-inflammatory agents.

The present invention provides dietary formulations comprising polyunsaturated fatty acids and vitamin E. The present invention further provides methods of treating various conditions, generally involving administering to an individual in need thereof an effective amount of a subject dietary formulation.

The invention provides methods, compositions, and dietary formulations useful for preventing or treating dermatitis, promoting healthy skin, and retarding skin aging. The methods comprise administering to an animal a therapeutically effective amount of a combination of at least two of one or more antioxidants; one or more anti-glycation agents; one or more body fat reducing agents; one or more insulin sensitivity enhancing agents; and one or more anti-inflammatory agents.

The invention relates to a dissolving strip for drug delivery providing a generally inert water soluble base material attached to the maxillary molars in order to deliver a therapeutic material upon activation by the parotid and other oral salivary glands. The composition of the dissolving strip is a generally inert base material, such as pullulan. The pullulan is impregnated with a therapeutic material to form a solid mixture to carry the therapeutic agent. The dissolving strip has sufficient flexibility to adhere to the 1-4 maxillary molars and acts as a reservoir to deliver therapeutic agents, such as an anti-smoking formula, a diet formula, a sexual enhancement formula, an oral freshness formula, prescription drugs, non-prescription drugs, herbs, or vitamins, or any combination of the previously listed. The dissolving strip is capable of delivering the therapeutic agents in a sustained or time released fashion.

The invention discloses a ketogenic diet formula powder, and the technical problem to be solved is to exercise the chewing ability of infants and improve the therapeutic effect of the ketogenic diet. The ketogenic diet formula powder of the present invention is composed of the following components in mass ratio: 55-75 parts of fat, 10-21 parts of protein, 4-22.5 parts of carbohydrates, 3.2-4.5 parts of vitamins and minerals, and 0.6-25 parts of L-carnitine. 3.0 parts, 0.1-0.15 parts of taurine, 0.4-2.0 parts of food additives, food additives are emulsifiers, acidity regulators and sweeteners. Compared with the prior art, the ketogenic diet formula powder in the present invention is in a paste form after being prepared with warm water, which can effectively prevent patients with swallowing dysfunction from choking on milk. Chewing ability, the patient can form glue with glucose in the gastrointestinal tract after eating, which can slow down the absorption of glucose and stabilize the blood sugar after meals, so that the blood ketone level after meals can also be maintained stable, improving the therapeutic effect of ketogenic diet.

The invention especially relates to a dietary formulation and a formulation card, belonging to the technical field of dietary formulations. With 1000 ml of the dietary formulation providing 1000 kcalas a standard, the dietary formulation contains 67 g of proteins, 21 g of fat and 110 g of carbohydrates, wherein the content of high-quality proteins is greater than 50%. The dietary formulation of the invention is targeted to protein malnutrition, and can supplement sufficient nutrients, increase the supply of animal proteins, vegetable proteins and fresh vegetable and realize symptomatic treatment of the disturbance of water and electrolyte and skin damage. At the same time, through cooperative usage of the formulation card of the invention, a plurality of formulations can be obtained, andthe card is convenient to use.

The invention discloses a dietetic medicament for the auxiliary treatment of hepatitis which is prepared from water extracts of Chinese medicinal climbing fern spore and Glochidion puberum. The medicament is effective in treating both hepatitis A and hepatitis B.

The present invention relates to dietary formulations for the slow release of water-soluble active ingredients. Said formulations comprise a coating obtained by evaporation from vinyl polymer dispersions not containing emulsifiers. The formulations can be advantageously included in an edible composition, including confectionery products.

The invention provides methods for the treatment of cancer, reduction of cancer risk, or prevention of cancer in a companion animal, comprising: identifying the companion animal having cancer or at risk for cancer and feeding a dietary formulation in a therapeutically effective amount to the animal. The dietary formulation can comprise 20% to 60% protein; 10% to 40% fat; 10% to 50% carbohydrates; and 0.01% to 5% alpha-amylase inhibitor, and optionally 1% to 50% resistant starch. The therapeutically effective amount can be effective for the treatment of cancer, the prevention of cancer, or the reduction of cancer risk in the companion animal by lowering the postprandial blood glucose of the companion animal as compared to the postprandial blood glucose of the companion animal ingesting a comparable dietary formulation that excludes the alpha-amylase inhibitor.